Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4548390
Max Phase: Preclinical
Molecular Formula: C186H313N53O54
Molecular Weight: 4155.87
Molecule Type: Unknown
Associated Items:
ID: ALA4548390
Max Phase: Preclinical
Molecular Formula: C186H313N53O54
Molecular Weight: 4155.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C186H313N53O54/c1-93(2)75-122(227-176(286)146(100(15)16)233-169(279)128(81-99(13)14)228-179(289)150(104(20)247)238-173(283)134(91-243)232-167(277)127(80-98(11)12)225-158(268)116(59-65-137(188)252)217-171(281)132(89-241)230-163(273)123(76-94(3)4)211-142(257)69-63-120(182(292)293)210-141(256)48-36-34-32-30-28-26-24-22-23-25-27-29-31-33-35-37-49-145(260)261)153(263)206-86-143(258)209-111(43-38-70-202-183(193)194)154(264)222-126(79-97(9)10)166(276)231-133(90-242)172(282)216-115(58-64-136(187)251)157(267)213-112(44-39-71-203-184(195)196)155(265)224-125(78-96(7)8)165(275)226-129(84-108-85-201-92-208-108)168(278)214-113(45-40-72-204-185(197)198)156(266)223-124(77-95(5)6)164(274)215-117(60-66-138(189)253)160(270)237-151(105(21)248)180(290)229-130(83-107-52-56-110(250)57-53-107)181(291)239-74-42-47-135(239)174(284)219-114(46-41-73-205-186(199)200)159(269)235-148(102(18)245)177(287)220-119(62-68-140(191)255)162(272)234-147(101(17)244)175(285)207-87-144(259)212-131(88-240)170(280)218-118(61-67-139(190)254)161(271)236-149(103(19)246)178(288)221-121(152(192)262)82-106-50-54-109(249)55-51-106/h50-57,85,92-105,111-135,146-151,240-250H,22-49,58-84,86-91H2,1-21H3,(H2,187,251)(H2,188,252)(H2,189,253)(H2,190,254)(H2,191,255)(H2,192,262)(H,201,208)(H,206,263)(H,207,285)(H,209,258)(H,210,256)(H,211,257)(H,212,259)(H,213,267)(H,214,278)(H,215,274)(H,216,282)(H,217,281)(H,218,280)(H,219,284)(H,220,287)(H,221,288)(H,222,264)(H,223,266)(H,224,265)(H,225,268)(H,226,275)(H,227,286)(H,228,289)(H,229,290)(H,230,273)(H,231,276)(H,232,277)(H,233,279)(H,234,272)(H,235,269)(H,236,271)(H,237,270)(H,238,283)(H,260,261)(H,292,293)(H4,193,194,202)(H4,195,196,203)(H4,197,198,204)(H4,199,200,205)/t101-,102-,103-,104-,105-,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,132+,133+,134+,135+,146+,147+,148+,149+,150+,151+/m1/s1
Standard InChI Key: BDVMCGLRNXREBS-ZRSANWLQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 4155.87 | Molecular Weight (Monoisotopic): 4153.3375 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2017) Amylin and calcitonin receptor agonist, |
Source(1):